Global Hormone Sensitive Prostate Cancer Drugs Market Growth (Status and Outlook) 2026-2032
The global Hormone Sensitive Prostate Cancer Drugs market size is predicted to grow from US$ 168 million in 2025 to US$ 343 million in 2032; it is expected to grow at a CAGR of 10.9% from 2026 to 2032.
Hormone-sensitive prostate cancer (HSPC) drugs are a class of medications used to treat prostate cancer that is dependent on androgens, or male hormones, to grow and spread. These drugs work by reducing or blocking the production of androgens in the body, mainly testosterone, or by inhibiting androgen receptors on cancer cells. This hormonal therapy aims to slow down or stop the progression of cancer by depriving cancer cells of the hormones they need to grow. Common drugs in this category include androgen deprivation therapies (ADTs) like LHRH agonists, LHRH antagonists, and anti-androgens.
United States market for Hormone Sensitive Prostate Cancer Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Hormone Sensitive Prostate Cancer Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Hormone Sensitive Prostate Cancer Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Hormone Sensitive Prostate Cancer Drugs players cover Novartis, Merc & Co., Bristol-Myers, Dendreon Corporation, GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Hormone Sensitive Prostate Cancer Drugs Industry Forecast” looks at past sales and reviews total world Hormone Sensitive Prostate Cancer Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Hormone Sensitive Prostate Cancer Drugs sales for 2026 through 2032. With Hormone Sensitive Prostate Cancer Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hormone Sensitive Prostate Cancer Drugs industry.
This Insight Report provides a comprehensive analysis of the global Hormone Sensitive Prostate Cancer Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hormone Sensitive Prostate Cancer Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hormone Sensitive Prostate Cancer Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hormone Sensitive Prostate Cancer Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hormone Sensitive Prostate Cancer Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Hormone Sensitive Prostate Cancer Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
The report requires updating with new data and is sent in 48 hours after order is placed.
Hormone-sensitive prostate cancer (HSPC) drugs are a class of medications used to treat prostate cancer that is dependent on androgens, or male hormones, to grow and spread. These drugs work by reducing or blocking the production of androgens in the body, mainly testosterone, or by inhibiting androgen receptors on cancer cells. This hormonal therapy aims to slow down or stop the progression of cancer by depriving cancer cells of the hormones they need to grow. Common drugs in this category include androgen deprivation therapies (ADTs) like LHRH agonists, LHRH antagonists, and anti-androgens.
United States market for Hormone Sensitive Prostate Cancer Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Hormone Sensitive Prostate Cancer Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Hormone Sensitive Prostate Cancer Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Hormone Sensitive Prostate Cancer Drugs players cover Novartis, Merc & Co., Bristol-Myers, Dendreon Corporation, GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Hormone Sensitive Prostate Cancer Drugs Industry Forecast” looks at past sales and reviews total world Hormone Sensitive Prostate Cancer Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Hormone Sensitive Prostate Cancer Drugs sales for 2026 through 2032. With Hormone Sensitive Prostate Cancer Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hormone Sensitive Prostate Cancer Drugs industry.
This Insight Report provides a comprehensive analysis of the global Hormone Sensitive Prostate Cancer Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hormone Sensitive Prostate Cancer Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hormone Sensitive Prostate Cancer Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hormone Sensitive Prostate Cancer Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hormone Sensitive Prostate Cancer Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Hormone Sensitive Prostate Cancer Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Androgen Ablation Therapy
- Anti-androgens
- Chemotherapy
- Targeted Therapy
- Hospitals
- Clinics
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Merc & Co.
- Bristol-Myers
- Dendreon Corporation
- GlaxoSmithKline
- Ferring
- Roche
- Celgen
- Amgen
- Teva
- Bayer
- Pfizer
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hormone Sensitive Prostate Cancer Drugs Market Size (2021-2032)
2.1.2 Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Hormone Sensitive Prostate Cancer Drugs by Country/Region (2021, 2025 & 2032)
2.2 Hormone Sensitive Prostate Cancer Drugs Segment by Type
2.2.1 Androgen Ablation Therapy
2.2.2 Anti-androgens
2.2.3 Chemotherapy
2.2.4 Targeted Therapy
2.2.5 Hormone Sensitive Prostate Cancer Drugs Market Size by Type
2.2.5.1 Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
2.3 Hormone Sensitive Prostate Cancer Drugs Segment by Application
2.3.1 Hospitals
2.3.2 Clinics
2.3.3 Other
2.3.4 Hormone Sensitive Prostate Cancer Drugs Market Size by Application
2.3.4.1 Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
3 HORMONE SENSITIVE PROSTATE CANCER DRUGS MARKET SIZE BY PLAYER
3.1 Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Player
3.1.1 Global Hormone Sensitive Prostate Cancer Drugs Revenue by Player (2021-2026)
3.1.2 Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Hormone Sensitive Prostate Cancer Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HORMONE SENSITIVE PROSTATE CANCER DRUGS BY REGION
4.1 Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021-2026)
4.2 Global Hormone Sensitive Prostate Cancer Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hormone Sensitive Prostate Cancer Drugs Market Size Growth (2021-2026)
4.4 APAC Hormone Sensitive Prostate Cancer Drugs Market Size Growth (2021-2026)
4.5 Europe Hormone Sensitive Prostate Cancer Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021-2026)
5.2 Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026)
5.3 Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021-2026)
6.2 APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026)
6.3 APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021-2026)
7.2 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026)
7.3 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs by Region (2021-2026)
8.2 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HORMONE SENSITIVE PROSTATE CANCER DRUGS MARKET FORECAST
10.1 Global Hormone Sensitive Prostate Cancer Drugs Forecast by Region (2027-2032)
10.1.1 Global Hormone Sensitive Prostate Cancer Drugs Forecast by Region (2027-2032)
10.1.2 Americas Hormone Sensitive Prostate Cancer Drugs Forecast
10.1.3 APAC Hormone Sensitive Prostate Cancer Drugs Forecast
10.1.4 Europe Hormone Sensitive Prostate Cancer Drugs Forecast
10.1.5 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Forecast
10.2 Americas Hormone Sensitive Prostate Cancer Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.2.2 Canada Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.2.3 Mexico Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.2.4 Brazil Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.3 APAC Hormone Sensitive Prostate Cancer Drugs Forecast by Region (2027-2032)
10.3.1 China Hormone Sensitive Prostate Cancer Drugs Market Forecast
10.3.2 Japan Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.3.3 Korea Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.3.4 Southeast Asia Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.3.5 India Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.3.6 Australia Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.4 Europe Hormone Sensitive Prostate Cancer Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.4.2 France Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.4.3 UK Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.4.4 Italy Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.4.5 Russia Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.5 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.5.2 South Africa Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.5.3 Israel Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.5.4 Turkey Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.6 Global Hormone Sensitive Prostate Cancer Drugs Forecast by Type (2027-2032)
10.7 Global Hormone Sensitive Prostate Cancer Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Hormone Sensitive Prostate Cancer Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Hormone Sensitive Prostate Cancer Drugs Product Offered
11.1.3 Novartis Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Merc & Co.
11.2.1 Merc & Co. Company Information
11.2.2 Merc & Co. Hormone Sensitive Prostate Cancer Drugs Product Offered
11.2.3 Merc & Co. Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merc & Co. Main Business Overview
11.2.5 Merc & Co. Latest Developments
11.3 Bristol-Myers
11.3.1 Bristol-Myers Company Information
11.3.2 Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Product Offered
11.3.3 Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bristol-Myers Main Business Overview
11.3.5 Bristol-Myers Latest Developments
11.4 Dendreon Corporation
11.4.1 Dendreon Corporation Company Information
11.4.2 Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Product Offered
11.4.3 Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Dendreon Corporation Main Business Overview
11.4.5 Dendreon Corporation Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Product Offered
11.5.3 GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Ferring
11.6.1 Ferring Company Information
11.6.2 Ferring Hormone Sensitive Prostate Cancer Drugs Product Offered
11.6.3 Ferring Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Ferring Main Business Overview
11.6.5 Ferring Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Hormone Sensitive Prostate Cancer Drugs Product Offered
11.7.3 Roche Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Celgen
11.8.1 Celgen Company Information
11.8.2 Celgen Hormone Sensitive Prostate Cancer Drugs Product Offered
11.8.3 Celgen Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Celgen Main Business Overview
11.8.5 Celgen Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Hormone Sensitive Prostate Cancer Drugs Product Offered
11.9.3 Amgen Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Teva
11.10.1 Teva Company Information
11.10.2 Teva Hormone Sensitive Prostate Cancer Drugs Product Offered
11.10.3 Teva Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Teva Main Business Overview
11.10.5 Teva Latest Developments
11.11 Bayer
11.11.1 Bayer Company Information
11.11.2 Bayer Hormone Sensitive Prostate Cancer Drugs Product Offered
11.11.3 Bayer Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bayer Main Business Overview
11.11.5 Bayer Latest Developments
11.12 Pfizer
11.12.1 Pfizer Company Information
11.12.2 Pfizer Hormone Sensitive Prostate Cancer Drugs Product Offered
11.12.3 Pfizer Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Pfizer Main Business Overview
11.12.5 Pfizer Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hormone Sensitive Prostate Cancer Drugs Market Size (2021-2032)
2.1.2 Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Hormone Sensitive Prostate Cancer Drugs by Country/Region (2021, 2025 & 2032)
2.2 Hormone Sensitive Prostate Cancer Drugs Segment by Type
2.2.1 Androgen Ablation Therapy
2.2.2 Anti-androgens
2.2.3 Chemotherapy
2.2.4 Targeted Therapy
2.2.5 Hormone Sensitive Prostate Cancer Drugs Market Size by Type
2.2.5.1 Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
2.3 Hormone Sensitive Prostate Cancer Drugs Segment by Application
2.3.1 Hospitals
2.3.2 Clinics
2.3.3 Other
2.3.4 Hormone Sensitive Prostate Cancer Drugs Market Size by Application
2.3.4.1 Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
3 HORMONE SENSITIVE PROSTATE CANCER DRUGS MARKET SIZE BY PLAYER
3.1 Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Player
3.1.1 Global Hormone Sensitive Prostate Cancer Drugs Revenue by Player (2021-2026)
3.1.2 Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Hormone Sensitive Prostate Cancer Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HORMONE SENSITIVE PROSTATE CANCER DRUGS BY REGION
4.1 Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021-2026)
4.2 Global Hormone Sensitive Prostate Cancer Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hormone Sensitive Prostate Cancer Drugs Market Size Growth (2021-2026)
4.4 APAC Hormone Sensitive Prostate Cancer Drugs Market Size Growth (2021-2026)
4.5 Europe Hormone Sensitive Prostate Cancer Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021-2026)
5.2 Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026)
5.3 Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021-2026)
6.2 APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026)
6.3 APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021-2026)
7.2 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026)
7.3 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs by Region (2021-2026)
8.2 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HORMONE SENSITIVE PROSTATE CANCER DRUGS MARKET FORECAST
10.1 Global Hormone Sensitive Prostate Cancer Drugs Forecast by Region (2027-2032)
10.1.1 Global Hormone Sensitive Prostate Cancer Drugs Forecast by Region (2027-2032)
10.1.2 Americas Hormone Sensitive Prostate Cancer Drugs Forecast
10.1.3 APAC Hormone Sensitive Prostate Cancer Drugs Forecast
10.1.4 Europe Hormone Sensitive Prostate Cancer Drugs Forecast
10.1.5 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Forecast
10.2 Americas Hormone Sensitive Prostate Cancer Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.2.2 Canada Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.2.3 Mexico Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.2.4 Brazil Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.3 APAC Hormone Sensitive Prostate Cancer Drugs Forecast by Region (2027-2032)
10.3.1 China Hormone Sensitive Prostate Cancer Drugs Market Forecast
10.3.2 Japan Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.3.3 Korea Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.3.4 Southeast Asia Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.3.5 India Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.3.6 Australia Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.4 Europe Hormone Sensitive Prostate Cancer Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.4.2 France Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.4.3 UK Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.4.4 Italy Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.4.5 Russia Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.5 Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.5.2 South Africa Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.5.3 Israel Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.5.4 Turkey Market Hormone Sensitive Prostate Cancer Drugs Forecast
10.6 Global Hormone Sensitive Prostate Cancer Drugs Forecast by Type (2027-2032)
10.7 Global Hormone Sensitive Prostate Cancer Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Hormone Sensitive Prostate Cancer Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Hormone Sensitive Prostate Cancer Drugs Product Offered
11.1.3 Novartis Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Merc & Co.
11.2.1 Merc & Co. Company Information
11.2.2 Merc & Co. Hormone Sensitive Prostate Cancer Drugs Product Offered
11.2.3 Merc & Co. Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merc & Co. Main Business Overview
11.2.5 Merc & Co. Latest Developments
11.3 Bristol-Myers
11.3.1 Bristol-Myers Company Information
11.3.2 Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Product Offered
11.3.3 Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bristol-Myers Main Business Overview
11.3.5 Bristol-Myers Latest Developments
11.4 Dendreon Corporation
11.4.1 Dendreon Corporation Company Information
11.4.2 Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Product Offered
11.4.3 Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Dendreon Corporation Main Business Overview
11.4.5 Dendreon Corporation Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Product Offered
11.5.3 GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Ferring
11.6.1 Ferring Company Information
11.6.2 Ferring Hormone Sensitive Prostate Cancer Drugs Product Offered
11.6.3 Ferring Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Ferring Main Business Overview
11.6.5 Ferring Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Hormone Sensitive Prostate Cancer Drugs Product Offered
11.7.3 Roche Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Celgen
11.8.1 Celgen Company Information
11.8.2 Celgen Hormone Sensitive Prostate Cancer Drugs Product Offered
11.8.3 Celgen Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Celgen Main Business Overview
11.8.5 Celgen Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Hormone Sensitive Prostate Cancer Drugs Product Offered
11.9.3 Amgen Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Teva
11.10.1 Teva Company Information
11.10.2 Teva Hormone Sensitive Prostate Cancer Drugs Product Offered
11.10.3 Teva Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Teva Main Business Overview
11.10.5 Teva Latest Developments
11.11 Bayer
11.11.1 Bayer Company Information
11.11.2 Bayer Hormone Sensitive Prostate Cancer Drugs Product Offered
11.11.3 Bayer Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bayer Main Business Overview
11.11.5 Bayer Latest Developments
11.12 Pfizer
11.12.1 Pfizer Company Information
11.12.2 Pfizer Hormone Sensitive Prostate Cancer Drugs Product Offered
11.12.3 Pfizer Hormone Sensitive Prostate Cancer Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Pfizer Main Business Overview
11.12.5 Pfizer Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Hormone Sensitive Prostate Cancer Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Androgen Ablation Therapy
Table 4. Major Players of Anti-androgens
Table 5. Major Players of Chemotherapy
Table 6. Major Players of Targeted Therapy
Table 7. Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
Table 10. Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
Table 13. Global Hormone Sensitive Prostate Cancer Drugs Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Player (2021-2026)
Table 15. Hormone Sensitive Prostate Cancer Drugs Key Players Head office and Products Offered
Table 16. Hormone Sensitive Prostate Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Region (2021-2026)
Table 21. Global Hormone Sensitive Prostate Cancer Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Country (2021-2026)
Table 25. Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
Table 27. Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
Table 29. APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Region (2021-2026)
Table 31. APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Country (2021-2026)
Table 35. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Hormone Sensitive Prostate Cancer Drugs
Table 41. Key Market Challenges & Risks of Hormone Sensitive Prostate Cancer Drugs
Table 42. Key Industry Trends of Hormone Sensitive Prostate Cancer Drugs
Table 43. Global Hormone Sensitive Prostate Cancer Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Hormone Sensitive Prostate Cancer Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Hormone Sensitive Prostate Cancer Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Novartis Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 48. Novartis Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 49. Novartis Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Novartis Main Business
Table 51. Novartis Latest Developments
Table 52. Merc & Co. Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 53. Merc & Co. Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 54. Merc & Co. Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Merc & Co. Main Business
Table 56. Merc & Co. Latest Developments
Table 57. Bristol-Myers Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 58. Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 59. Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Bristol-Myers Main Business
Table 61. Bristol-Myers Latest Developments
Table 62. Dendreon Corporation Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 63. Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 64. Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Dendreon Corporation Main Business
Table 66. Dendreon Corporation Latest Developments
Table 67. GlaxoSmithKline Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 68. GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 69. GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. GlaxoSmithKline Main Business
Table 71. GlaxoSmithKline Latest Developments
Table 72. Ferring Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 73. Ferring Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 74. Ferring Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Ferring Main Business
Table 76. Ferring Latest Developments
Table 77. Roche Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 78. Roche Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 79. Roche Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Roche Main Business
Table 81. Roche Latest Developments
Table 82. Celgen Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 83. Celgen Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 84. Celgen Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Celgen Main Business
Table 86. Celgen Latest Developments
Table 87. Amgen Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 88. Amgen Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 89. Amgen Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Amgen Main Business
Table 91. Amgen Latest Developments
Table 92. Teva Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 93. Teva Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 94. Teva Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Teva Main Business
Table 96. Teva Latest Developments
Table 97. Bayer Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 98. Bayer Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 99. Bayer Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Bayer Main Business
Table 101. Bayer Latest Developments
Table 102. Pfizer Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 103. Pfizer Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 104. Pfizer Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Pfizer Main Business
Table 106. Pfizer Latest Developments
Table 1. Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Hormone Sensitive Prostate Cancer Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Androgen Ablation Therapy
Table 4. Major Players of Anti-androgens
Table 5. Major Players of Chemotherapy
Table 6. Major Players of Targeted Therapy
Table 7. Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
Table 10. Hormone Sensitive Prostate Cancer Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
Table 13. Global Hormone Sensitive Prostate Cancer Drugs Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Player (2021-2026)
Table 15. Hormone Sensitive Prostate Cancer Drugs Key Players Head office and Products Offered
Table 16. Hormone Sensitive Prostate Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Region (2021-2026)
Table 21. Global Hormone Sensitive Prostate Cancer Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Country (2021-2026)
Table 25. Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
Table 27. Americas Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
Table 29. APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Region (2021-2026)
Table 31. APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Country (2021-2026)
Table 35. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Hormone Sensitive Prostate Cancer Drugs
Table 41. Key Market Challenges & Risks of Hormone Sensitive Prostate Cancer Drugs
Table 42. Key Industry Trends of Hormone Sensitive Prostate Cancer Drugs
Table 43. Global Hormone Sensitive Prostate Cancer Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Hormone Sensitive Prostate Cancer Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Hormone Sensitive Prostate Cancer Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Novartis Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 48. Novartis Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 49. Novartis Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Novartis Main Business
Table 51. Novartis Latest Developments
Table 52. Merc & Co. Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 53. Merc & Co. Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 54. Merc & Co. Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Merc & Co. Main Business
Table 56. Merc & Co. Latest Developments
Table 57. Bristol-Myers Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 58. Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 59. Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Bristol-Myers Main Business
Table 61. Bristol-Myers Latest Developments
Table 62. Dendreon Corporation Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 63. Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 64. Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Dendreon Corporation Main Business
Table 66. Dendreon Corporation Latest Developments
Table 67. GlaxoSmithKline Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 68. GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 69. GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. GlaxoSmithKline Main Business
Table 71. GlaxoSmithKline Latest Developments
Table 72. Ferring Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 73. Ferring Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 74. Ferring Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Ferring Main Business
Table 76. Ferring Latest Developments
Table 77. Roche Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 78. Roche Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 79. Roche Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Roche Main Business
Table 81. Roche Latest Developments
Table 82. Celgen Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 83. Celgen Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 84. Celgen Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Celgen Main Business
Table 86. Celgen Latest Developments
Table 87. Amgen Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 88. Amgen Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 89. Amgen Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Amgen Main Business
Table 91. Amgen Latest Developments
Table 92. Teva Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 93. Teva Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 94. Teva Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Teva Main Business
Table 96. Teva Latest Developments
Table 97. Bayer Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 98. Bayer Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 99. Bayer Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Bayer Main Business
Table 101. Bayer Latest Developments
Table 102. Pfizer Details, Company Type, Hormone Sensitive Prostate Cancer Drugs Area Served and Its Competitors
Table 103. Pfizer Hormone Sensitive Prostate Cancer Drugs Product Offered
Table 104. Pfizer Hormone Sensitive Prostate Cancer Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Pfizer Main Business
Table 106. Pfizer Latest Developments
LIST OF FIGURES
Figure 1. Hormone Sensitive Prostate Cancer Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Hormone Sensitive Prostate Cancer Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Hormone Sensitive Prostate Cancer Drugs Sales Market Share by Country/Region (2025)
Figure 8. Hormone Sensitive Prostate Cancer Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type in 2025
Figure 10. Hormone Sensitive Prostate Cancer Drugs in Hospitals
Figure 11. Global Hormone Sensitive Prostate Cancer Drugs Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Hormone Sensitive Prostate Cancer Drugs in Clinics
Figure 13. Global Hormone Sensitive Prostate Cancer Drugs Market: Clinics (2021-2026) & ($ millions)
Figure 14. Hormone Sensitive Prostate Cancer Drugs in Other
Figure 15. Global Hormone Sensitive Prostate Cancer Drugs Market: Other (2021-2026) & ($ millions)
Figure 16. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application in 2025
Figure 17. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Player in 2025
Figure 18. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Region (2021-2026)
Figure 19. Americas Hormone Sensitive Prostate Cancer Drugs Market Size 2021-2026 ($ millions)
Figure 20. APAC Hormone Sensitive Prostate Cancer Drugs Market Size 2021-2026 ($ millions)
Figure 21. Europe Hormone Sensitive Prostate Cancer Drugs Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size 2021-2026 ($ millions)
Figure 23. Americas Hormone Sensitive Prostate Cancer Drugs Value Market Share by Country in 2025
Figure 24. United States Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Region in 2025
Figure 29. APAC Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
Figure 30. APAC Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
Figure 31. China Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. India Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Country in 2025
Figure 38. Europe Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
Figure 39. Europe Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
Figure 40. Germany Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. France Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 54. APAC Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 55. Europe Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 57. United States Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 58. Canada Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 59. Mexico Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 60. Brazil Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 61. China Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 62. Japan Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 63. Korea Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 65. India Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 66. Australia Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 67. Germany Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 68. France Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 69. UK Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 70. Italy Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 71. Russia Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 72. Egypt Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 73. South Africa Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 74. Israel Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 75. Turkey Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 76. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 1. Hormone Sensitive Prostate Cancer Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Hormone Sensitive Prostate Cancer Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Hormone Sensitive Prostate Cancer Drugs Sales Market Share by Country/Region (2025)
Figure 8. Hormone Sensitive Prostate Cancer Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type in 2025
Figure 10. Hormone Sensitive Prostate Cancer Drugs in Hospitals
Figure 11. Global Hormone Sensitive Prostate Cancer Drugs Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Hormone Sensitive Prostate Cancer Drugs in Clinics
Figure 13. Global Hormone Sensitive Prostate Cancer Drugs Market: Clinics (2021-2026) & ($ millions)
Figure 14. Hormone Sensitive Prostate Cancer Drugs in Other
Figure 15. Global Hormone Sensitive Prostate Cancer Drugs Market: Other (2021-2026) & ($ millions)
Figure 16. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application in 2025
Figure 17. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Player in 2025
Figure 18. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Region (2021-2026)
Figure 19. Americas Hormone Sensitive Prostate Cancer Drugs Market Size 2021-2026 ($ millions)
Figure 20. APAC Hormone Sensitive Prostate Cancer Drugs Market Size 2021-2026 ($ millions)
Figure 21. Europe Hormone Sensitive Prostate Cancer Drugs Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size 2021-2026 ($ millions)
Figure 23. Americas Hormone Sensitive Prostate Cancer Drugs Value Market Share by Country in 2025
Figure 24. United States Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Region in 2025
Figure 29. APAC Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
Figure 30. APAC Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
Figure 31. China Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. India Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Country in 2025
Figure 38. Europe Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
Figure 39. Europe Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
Figure 40. Germany Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. France Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Hormone Sensitive Prostate Cancer Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 54. APAC Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 55. Europe Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 57. United States Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 58. Canada Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 59. Mexico Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 60. Brazil Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 61. China Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 62. Japan Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 63. Korea Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 65. India Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 66. Australia Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 67. Germany Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 68. France Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 69. UK Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 70. Italy Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 71. Russia Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 72. Egypt Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 73. South Africa Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 74. Israel Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 75. Turkey Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
Figure 76. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Hormone Sensitive Prostate Cancer Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Hormone Sensitive Prostate Cancer Drugs Market Size 2027-2032 ($ millions)
